Neostigmine Methylsulfate Injection
Product Images NDC 70121-1479

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 70121-1479). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate Injection 1)

FDA Label Image

1 (Neostigmine Methylsulfate Injection 2)

FDA Label Image

1 (Neostigmine Methylsulfate Injection 3)

1 (Neostigmine Methylsulfate Injection 3)
Neostigmine Methylsulfate Injection is a medicine used for Intravenous Use packed in 10x 10 mL Multiple-Dose Vials. It contains 5mg/10 mL (0.5 my/ml) of Neostigmine Methylsulfate. The package is designed to be stored between 20 to 25°C (68 to 77°F), with excursions permitted at 15° to 30°C (59" to 86°F), and protected from light. The directions for use are available on the package. The manufacturer of Neostigmine Methylsulfate Injection is Amnea Pharmaceuticls Pt Lt.*
FDA Label Image

1 (Neostigmine Methylsulfate Injection 4)

1 (Neostigmine Methylsulfate Injection 4)
This is a description of a medication with the National Drug Code (NDC) 7012114781. The medication is Neostigmine Methylsulfate Injection intended for intravenous use, contained in a vial with a volume of 10 mL. The concentration of the medication in the vial is 1mg/mL. There is no further available information.*
FDA Label Image

1 (Neostigmine Methylsulfate Injection 5)

1 (Neostigmine Methylsulfate Injection 5)
Neostigmine Methylsulfate Injection, USP is a medication administered intravenously using 10 x 10 mL multiple-dose vials. Each milliliter contains Neostigmine Methylsulfate (1 mg), Phend (4.5 mg), and Sodum Aectte Tycate (0.2 mg). The solution is prepared by adjusting the pH with Sodum Hybou/iceic cd when necessary. The solution should be stored at 2° to 25°C, protected from light and excursions allowed between 5° to 30°C. The vial stopper is made of natural rubber.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.